 | |
| Company type | Private |
|---|---|
| Industry | Private equity |
| Founded | 1977 |
| Headquarters | London, United Kingdom |
Key people | Stuart McAlpine, Managing Partner |
| Products | Private equity |
| Website | www |
Cinven Limited is a global private equity firm founded in 1977, with offices in nine international locations in Guernsey, London, New York, Paris, Frankfurt, Milan, Luxembourg, Madrid, and Hong Kong that acquires Europe and United States–based corporations, and emerging market firms that fit with their core businesses, and necessitate a minimum equity investment of €100 million or more.[1] As of 2024, it has €44 billion in assets under management.
Cinven's funding base originally came solely from three pension funds in the United Kingdom (British Coal, the Railway Industry and Barclays Bank) who remain as important investors.[2] Cinven has been reported to originally stand for Coal Investment Nominees' for Venture Capital.[3]
Cinven invests in six sectors on an international basis: Business Services; Technology, Media and Telecommunications; Financial Services; Industrials; Healthcare; and Consumer.
In July 2021, the firm was fined £43m by the UK Competition and Markets Authority for its part in a generic drug pricefixing scandal, which had resulted in the National Health Service being overcharged by "hundreds of millions of pounds" over several years.[4]
In January 2024, Cinven raised $14.5 billion for its eighth private equity fund.[5]
- ^ Cinven, About us, Cinven website, retrieved April 2, 2016
- ^ The fourth Cinven fund completes fundraising at $6.5 billion Archived 16 March 2008 at the Wayback Machine, Cinven press release,30 June 2006
- ^ Cinven looks to rejoin industry's top league. Dow Jones Financial News, 8 September 2008
- ^ "Drug companies fined £260m for "colluding to overcharge the NHS"". 15 July 2021.
- ^ Gopinath, Swetha (9 January 2024). "Cinven Raises $14.5 Billion for UK Buyout Firm's Eighth Fund". Bloomberg News. Retrieved 22 January 2024.